Abstract
Controlling elevated tissue-specific levels of cortisol may provide a novel therapeutic approach for treating metabolic syndrome. This concept has spurred large scale medicinal chemistry efforts in the pharmaceutical industry for the design of 11β-HSD1 inhibitors. High resolution X-ray crystal structures of inhibitors in complex with the enzyme have facilitated the structure-based design of diverse classes of molecules. A summary of binding modes, trends in structure- activity relationships, and the pharmacodynamic data of inhibitors from each class is presented.
Keywords: Metabolic syndrome, 11β-HSD1, inhibitors, structure-based drug design, x-ray crystal structures, binding modes, structure-activity relationship, natural products, cortisone, cortisol, triazoles, aminothiazolones, sulfonamides, pharmacodynamic, hypothalamic-pituitary-adrenal axis, 11-hydroxyste-roid dehydrogenase types 1 and 2, 11-keto group, glucocorticoid cortisone 1, Q177Y, I180V, I227V, E226A, whole body inhibition, tissue specific in-hibition, short-chain alcohol dehydrogenase/reductase, triterpene 18-glycyrrhetinic acid, Carbenoxolone, Triazole, cyclopropyl-4-fluorobenzyl group, 18-glycyrrhetinic acid, polar 4-(2-pyridyl)piperazin-1-yl, amide carbonyl oxygen, Ser170, Tyr183 phenol, 3-fluoro-4-methyl substitution, cyclo-octylamino compound, benzylamino compounds, Leu171, aminothiazolone ring, thiazolone ring, AMG-221, sulfonamide, (2-hydroxy-1,1,1-trifluoro)-2-propyl group, CYP3A4 inhibitor
Current Pharmaceutical Biotechnology
Title: Structure Based Design of 11β-HSD1 Inhibitors
Volume: 11 Issue: 7
Author(s): Suresh B. Singh and Colin M. Tice
Affiliation:
Keywords: Metabolic syndrome, 11β-HSD1, inhibitors, structure-based drug design, x-ray crystal structures, binding modes, structure-activity relationship, natural products, cortisone, cortisol, triazoles, aminothiazolones, sulfonamides, pharmacodynamic, hypothalamic-pituitary-adrenal axis, 11-hydroxyste-roid dehydrogenase types 1 and 2, 11-keto group, glucocorticoid cortisone 1, Q177Y, I180V, I227V, E226A, whole body inhibition, tissue specific in-hibition, short-chain alcohol dehydrogenase/reductase, triterpene 18-glycyrrhetinic acid, Carbenoxolone, Triazole, cyclopropyl-4-fluorobenzyl group, 18-glycyrrhetinic acid, polar 4-(2-pyridyl)piperazin-1-yl, amide carbonyl oxygen, Ser170, Tyr183 phenol, 3-fluoro-4-methyl substitution, cyclo-octylamino compound, benzylamino compounds, Leu171, aminothiazolone ring, thiazolone ring, AMG-221, sulfonamide, (2-hydroxy-1,1,1-trifluoro)-2-propyl group, CYP3A4 inhibitor
Abstract: Controlling elevated tissue-specific levels of cortisol may provide a novel therapeutic approach for treating metabolic syndrome. This concept has spurred large scale medicinal chemistry efforts in the pharmaceutical industry for the design of 11β-HSD1 inhibitors. High resolution X-ray crystal structures of inhibitors in complex with the enzyme have facilitated the structure-based design of diverse classes of molecules. A summary of binding modes, trends in structure- activity relationships, and the pharmacodynamic data of inhibitors from each class is presented.
Export Options
About this article
Cite this article as:
B. Singh Suresh and M. Tice Colin, Structure Based Design of 11β-HSD1 Inhibitors, Current Pharmaceutical Biotechnology 2010; 11 (7) . https://dx.doi.org/10.2174/138920110792927748
DOI https://dx.doi.org/10.2174/138920110792927748 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Lifestyle Interventions for Cardiovascular Risk Reduction in Women with Breast Cancer
Current Cardiology Reviews Genomics-Based Identification of Molecular Mechanisms behind the Cancer Preventive Action of Phytochemicals: Potential and Challenges
Current Pharmaceutical Biotechnology Growth Factors and Chemokines: A Comparative Functional Approach Between Invertebrates and Vertebrates
Current Medicinal Chemistry Biomarkers of Chronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD), A Review of Published Patents and Patent Applications
Recent Patents on Biomarkers Development of FXR, PXR and CAR Agonists and Antagonists for Treatment of Liver Disorders
Current Topics in Medicinal Chemistry <i>In-Silico</i> and <i>In-Vitro</i> Analysis of Human <i>SOS1</i> Protein Causing Noonan Syndrome - A Novel Approach to Explore the Molecular Pathways
Current Genomics Transforming Growth Factor β Signaling Perturbation in the Loeys-Dietz Syndrome
Current Medicinal Chemistry Molecular Targets and Angiogenesis in Renal Cell Carcinoma, A Multitarget Approach: Mini Review
Current Drug Targets Signal Transduction Targets in Prostate Cancer
Current Signal Transduction Therapy Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis
Current Cancer Drug Targets Targeting the RAS Signaling Pathway in Malignant Hematologic Diseases
Current Drug Targets The Use of Antiparkinsonian Agents in the Management of Drug-Induced Extrapyramidal Symptoms
Current Pharmaceutical Design Role of Vitamin D in the Pathophysiology and Treatment of Type 2 Diabetes
Current Diabetes Reviews The mTOR Signaling Network: Insights from Its Role During Embryonic Development
Current Medicinal Chemistry Intestinal Immunomodulation. Role of Regulative Peptides and Promising Pharmacological Activities
Current Pharmaceutical Design Adherence to Antiretroviral Therapies: State of the Science
Current HIV Research Kidney in Diabetes: from Organ Damage Target to Therapeutic Target
Current Drug Metabolism Editorial [ The Wide Roles of Cytokines During Evolution Executive Editors: M. de Eguileor and E. Ottaviani ]
Current Pharmaceutical Design Hyperglycaemia and Vitamin D: A Systematic Overview
Current Diabetes Reviews Vitamin D and Metabolic Syndrome: Is There a Link?
Current Pharmaceutical Design